Advances in Surface Nano-Engineering of Nanomedicines: Physiochemical Characterization and In Vitro/In Vivo Evaluations
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Physical Chemistry".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 1537
Special Issue Editor
Interests: biopharmaceutics; polymeric nanoparticles; metal nanoparticles; liposomes; surface engineering of nanostructures; development and characterisation of nanomedicine; complement activation; controlled release solid dosage forms; transdermal drug delivery systems
Special Issue Information
Dear Colleagues,
The physico-chemical properties of nanoparticles, including their shape, size, charge, core structure, surface chemistry, and ligand properties play an important role as they may ultimately affect the in vitro and in vivo behavior of nanoparticles. In this respect, nanomedicines with desired physico-chemical properties are of great interest for successfully delivering many therapeutic agents to their target organs. There is also a growing interest in the physico-chemical modifications of nanomedicines’ surfaces (including soft and hard nanoparticles based on metals, inorganic compounds, lipids, and polymers) in the design of nanomedicines for active targeting. Surface engineering through conjugation of ligands to nanoparticles’ surfaces is also another emerging topic to be discussed.
We are launching the Special Issue “Advances in Surface Nano-Engineering of Nanomedicines: Physicochemical Characterization and in Vitro / In Vivo Evaluations” in order to highlight recent advances in the field and share the latest experimental findings related to the formation, characterization, and in vitro/in vivo evaluations of nanoparticles—including hard nanoparticles, solid lipid nanoparticles, and liposomes and other related lipid–nano-self-assemblies—as well as their surface nanoengineering for active drug targeting applications. Contributions emphasizing upcoming opportunities in this research area and discussing factors affecting the successful development of surface engineered nanoparticles for active drug targeting are also welcomed. Considering the multidisciplinary nature of the research area, this issue will collect original research and review articles from interested researchers with different backgrounds including drug delivery, biophysics, physical chemistry, and nanotechnology.
Dr. Islam Hamad
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
